U.S. federal trademark · Serial No. 99271923 · Reg. No. 8236051
Medical diagnostic testing services, namely, providing in-depth molecular analysis of tumor cells and tumor-derived genetic material for the purposes of assessing tumor burden, detecting genetic alterations, guiding personalized treatment selection, monitoring therapeutic response, and detecting recurrence in cancer patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.